Latest News
-
From the Journals
COVID-19–related inflammatory syndrome tied to neurologic symptoms in children
-
From the Journals
Transcranial brain stimulation can modulate placebo and nocebo experiences
It remains to be seen if this method could eventually alter chronic pain.
Conference Coverage
-
Conference Coverage
Common MS treatment wears off more quickly in Black patients
These findings may have implications for the way Black patients with autoimmune diseases are treated in the future.
-
Conference Coverage
Rimegepant looks safe in migraine patients with cardiovascular risk
Multiple-use safety study shows similar frequency of adverse events regardless of cardiovascular risk.
-
Conference Coverage
Study shows potential of remote Parkinson’s disease genotyping
A pilot study finds that remote genetic testing and counseling in Parkinson’s disease may have potential for casting a wider net for genetic data...
-
Conference Coverage
Stroke is ‘not a common complication’ in COVID-19
Among the sickest of COVID patients – those admitted to an ICU – researchers found that stroke was not a common complication.
-
Conference Coverage
The neurology of long-haul COVID-19
Clinical patterns and pathology are beginning to hint at the biology behind persistent neurologic complaints.
-
Conference Coverage
Investigative gepant liver profile comparable with standard of care
The investigative oral chronic migraine therapy atogepant had 1-year side-effect and hepatic function profiles comparable with the standard of...
-
Conference Coverage
Nondopamine antipsychotic shows clinical signal in Parkinson’s disease psychosis
Investigative schizophrenia drug SEP-363856 showed improvement in psychotic symptoms in Parkinson’s without worsening motor function.
-
Conference Coverage
Cannabis for migraine strongly linked to rebound headache
Are patients using cannabis to treat medication overuse headache, or is cannabis contributing to the development of said headaches, or both?
-
Conference Coverage
Evobrutinib may lower nerve damage biomarker levels
A post hoc analysis reports the Bruton’s tyrosine kinase inhibitor evobrutinib lowered neurofilament light chain blood levels in multiple...
-
Conference Coverage
Intranasal third-generation CGRP effective for acute migraine
Among patients taking zavegepant, more than 20% achieved pain freedom and 40% were relieved of their most bothersome symptom.
-
Conference Coverage
COVID-19 linked to novel epileptic seizures
Among patients with new-onset seizures, hospital stays were about 15 days longer – and mortality rates were significantly higher.
-
Conference Coverage
Long-term benefit for DBS in treating Parkinson’s disease motor symptoms
“Both STN and GPi DBS maintained motor benefit out to 10 years, with improvements seen in tremor and rigidity, greater than bradykinesia.”
-
Conference Coverage
Are psychiatric disorders a ‘canary in a coal mine’ for Alzheimer’s disease?
A chart review of 1,500 patients with Alzheimer’s disease identified a potential link between psychiatric disorders and younger onset of disease...
-
Conference Coverage
More reassurance for certain antiseizure drugs in pregnancy
Results show “no difference in verbal index or general conceptual ability scores in children born to women with epilepsy compared to children born...
-
Conference Coverage
VNS plus rehab is a powerful poststroke combination
An analysis found that outcomes for vagus nerve stimulation combined with rehabilitation for poststroke arm weakness exceeded rehabilitation alone...
-
Conference Coverage
Some MS treatments may heighten COVID risk
An Italian registry shows worse outcomes with anti-CD20 treatment, but a possible protective effect of interferon and teriflunomide.
-
Conference Coverage
Investigational drug reduces brain lesions in highly active MS
Tolebrutinib, a BTK inhibitor, reduced new gadolinium-enhancing lesions and new and enlarging T2 lesions.
-
Conference Coverage
NfL beats T-tau as a prognostic marker of cognitive decline
NfL was cross-sectionally associated with most cognitive outcomes; longitudinally, higher NfL at baseline was associated with cognitive decline in...
-
Conference Coverage
A new biomarker of traumatic brain injury?
“Von Willebrand factor may be more specific for acute injuries, given that it does not seem to stay chronically elevated.”
-
Conference Coverage
Once-nightly sodium oxybate agent effective in narcolepsy
All three doses of the novel agent were associated with significant improvements in sleep quality, refreshing nature of sleep, sleep paralysis,...
-
Conference Coverage
ADAPTABLE: Low-dose aspirin as good as high-dose in CHD?
A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found...
Literature Review
-
Literature Review
Basal ganglia microcircuits offer clues to Parkinson’s symptoms
In a mouse model of Parkinson’s disease, specific neuronal subpopulations, or microcircuits, in the basal ganglia could be manipulated to...
-
Literature Review
Race, ethnicity, and socioeconomics are often barriers to migraine care
People of African descent and Latinx ethnicity tend to fare worse than other people of color and their White counterparts.
Hitting a Nerve
-
Hitting a Nerve
The problem with samples
In many cases, the time you save handing out samples isn’t worth the time you have to spend on them down the line.